Cargando…

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

BACKGROUND: Exosomes are 50–150 nm endocytic vesicles secreted by almost all type of cells that carry bioactive molecules from host. These small vesicles are considered to be novel cross-talk circuits established by tumor cells and tumor microenvironment. Previous studies have shown certain biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chuling, Li, Chuwei, Zhi, Chunchun, Liang, Wenjun, Wang, Xuan, Chen, Xi, Lv, Tangfeng, Shen, Qin, Song, Yong, Lin, Dang, Liu, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820965/ https://www.ncbi.nlm.nih.gov/pubmed/31665020 http://dx.doi.org/10.1186/s12967-019-2101-2

Ejemplares similares

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023)

Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
por: Wang, Yimin, et al.
Publicado: (2022)

Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
por: Li, Huijuan, et al.
Publicado: (2022)

The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study
por: Zhang, Tianli, et al.
Publicado: (2020)

Contrast-enhanced computed tomography prior to percutaneous transthoracic needle biopsy reduces the incidence of hemorrhage
por: Hu, Huan, et al.
Publicado: (2021)

The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Li, Shujun, et al.
Publicado: (2022)

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2023)

The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients
por: Baran, Kamila, et al.
Publicado: (2023)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes
por: Meng, Fanyu, et al.
Publicado: (2023)

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
por: Tang, Yanyan, et al.
Publicado: (2020)

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
por: Del Re, Marzia, et al.
Publicado: (2018)

Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer
por: Xu, Qiuli, et al.
Publicado: (2021)

Retracted: The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Healthcare Engineering, Journal of
Publicado: (2023)

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
por: Niu, Mengke, et al.
Publicado: (2021)

Novel risk scoring system for immune checkpoint inhibitors treatment in non-small cell lung cancer
por: Li, Chuling, et al.
Publicado: (2021)

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level
por: Cao, Lianjing, et al.
Publicado: (2017)

CD39(+) Regulatory T Cells Attenuate Lipopolysaccharide-Induced Acute Lung Injury via Autophagy and the ERK/FOS Pathway
por: Chen, Cen, et al.
Publicado: (2021)

FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer
por: Liu, Jiaxin, et al.
Publicado: (2022)

Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
por: Zhang, Jie, et al.
Publicado: (2015)

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
por: Jiang, Li, et al.
Publicado: (2019)

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020)

The significance of PD-1/PD-L1 imbalance in ulcerative colitis
por: Shi, Wei, et al.
Publicado: (2023)

The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC
por: Shen, Kaikai, et al.
Publicado: (2021)

YAP regulates PD-L1 expression in human NSCLC cells
por: Miao, Jinbai, et al.
Publicado: (2017)

Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression
por: Lin, Ziying, et al.
Publicado: (2019)

Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer
por: Zhou, Li, et al.
Publicado: (2021)

Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
por: Zhang, Zhi-yao, et al.
Publicado: (2019)

Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential
por: Lin, Hongze, et al.
Publicado: (2023)

Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
por: Li, Xinying, et al.
Publicado: (2021)

Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
por: Li, Wenjie, et al.
Publicado: (2023)

PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC
por: Wu, Chiao-En, et al.
Publicado: (2020)

Various impacts of driver mutations on the PD-L1 expression of NSCLC
por: Chu, Cheng-Hsiang, et al.
Publicado: (2022)

The TLR4/ERK/PD-L1 axis may contribute to NSCLC initiation
por: Kang, Xiuhua, et al.
Publicado: (2020)

The efficacy and safety of anti-PD-1/PD-L1 antibody therapy versus docetaxel for pretreated advanced NSCLC: a meta-analysis
por: Huang, Guanghong, et al.
Publicado: (2017)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTOR
por: Hou, Zhibo, et al.
Publicado: (2020)

Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World
por: Zhu, Yefei, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of Twist overexpression in NSCLC
por: Li, Meng, et al.
Publicado: (2018)

Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non-small cell lung cancer
por: Gao, Jianwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tmn3lnhckioqm55lqtqnhc0e1c